Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals
about
Eicosanoid profiling in colon cancer: emergence of a patternHonokiol: a novel natural agent for cancer prevention and therapyThe novel Aryl hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor growth and peritoneal disseminationCalpain/SHP-1 interaction by honokiol dampening peritoneal dissemination of gastric cancer in nu/nu mice15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in?The role of peroxisome proliferator-activated receptors in the esophageal, gastric, and colorectal cancerCancer and diet: How are they related?Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia.Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinomaHonokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities.Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition.Molecular basis for the reduced catalytic activity of the naturally occurring T560M mutant of human 12/15-lipoxygenase that has been implicated in coronary artery disease.
P2860
Q26859889-F95D29D1-801B-4CAA-93AF-AC507F467945Q27027050-958FA7A0-1A47-413B-95C7-9AB6D6AC8B67Q34365882-1C27990C-94C3-4017-BACF-52AA3F22F4B9Q34399334-37CBC729-FFF5-47F2-B75E-90C848A72F4FQ35680221-20E777B1-8102-4FD2-89BF-755EA8FB34A5Q36238973-4FC5BF90-4E2F-40D6-B782-B316FEE327E8Q36587800-7EE18FDF-CDF5-4BA9-867F-AB6B0CEB9C1BQ36974684-561629DE-FA15-4499-A42A-8FE70BE9607EQ37031730-6B4346E2-5F2A-45F6-B552-2C2EE43123B9Q38104756-1BC1C324-2E19-44EB-8A3B-D335D7212194Q38916710-7E3CFE0A-4E73-4B99-B57A-D5AD6DAF4D4FQ41978118-E460468A-A6EE-4536-8ECB-47C334751CA1
P2860
Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-gamma and COX-2-dependent signals
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Honokiol inhibits gastric tumo ...... ma and COX-2-dependent signals
@ast
Honokiol inhibits gastric tumo ...... ma and COX-2-dependent signals
@en
Honokiol inhibits gastric tumo ...... ma and COX-2-dependent signals
@nl
type
label
Honokiol inhibits gastric tumo ...... ma and COX-2-dependent signals
@ast
Honokiol inhibits gastric tumo ...... ma and COX-2-dependent signals
@en
Honokiol inhibits gastric tumo ...... ma and COX-2-dependent signals
@nl
prefLabel
Honokiol inhibits gastric tumo ...... ma and COX-2-dependent signals
@ast
Honokiol inhibits gastric tumo ...... ma and COX-2-dependent signals
@en
Honokiol inhibits gastric tumo ...... ma and COX-2-dependent signals
@nl
P2093
P2860
P1476
Honokiol inhibits gastric tumo ...... ma and COX-2-dependent signals
@en
P2093
Chih Chien Wang
Chin Chang Shen
Hung Chuan Pan
Jaw Ji Tsai
Ju Ting Chueh
Keh Liang Lin
Meei Ling Sheu
Tso Ching Lee
Yu Chiao Yi
P2860
P304
P356
10.1111/J.1476-5381.2010.00804.X
P407
P577
2010-08-01T00:00:00Z